Login / Signup

Successful treatment with glecaprevir/pibrentasvir for chronic hepatitis C complicated by primary biliary cholangitis.

Satoshi TakakusagiHitoshi TakagiYozo YokoyamaKyoko MarubashiKazuko KizawaTakashi KosoneKen SatoSatoru KakizakiToshio Uraoka
Published in: Clinical journal of gastroenterology (2020)
GLE/PIB is an effective and tolerated choice for the treatment in cases of CHC complicated by PBC.
Keyphrases
  • pet imaging
  • combination therapy
  • decision making
  • liver fibrosis
  • hepatitis c virus infection